Nucleai — Software Company, Tel Aviv-Yafo
Software company · Tel Aviv-Yafo, Israel
AI Trust Snapshot
- Profile status
- Auto-indexed
Public channels checked
- ✓ Official Website
- ✓ Youtube
Key Facts
- Category
- Software Company
- Location
- Tel Aviv-Yafo, Israel
- Known For
- Geospatial AI methods for cellular analysis
AI Summary
Developing AI-driven diagnostic solutions, Nucleai applies geospatial AI methods for cellular analysis to support pharmaceutical companies and research institutions. The Tel Aviv-based organization specializes in biomarker discovery and validation, biomarker scoring, and companion diagnostics. It serves drug developers focused on next-generation therapeutics and spatial biology research.
Quick Answer
Developing AI-driven diagnostic solutions, Nucleai applies geospatial AI methods for cellular analysis to support pharmaceutical companies and research institutions. The Tel Aviv-based organization specializes in biomarker discovery and validation, biomarker scoring, and companion diagnostics. It serves drug developers focused on next-generation therapeutics and spatial biology research. Key services include Biomarker Discovery & Validation, Biomarker Scoring, Companion Diagnostics.
This business is typically used for geospatial ai methods for cellular analysis.
Common Questions
- What services does Nucleai provide?
- Nucleai provides Biomarker Discovery & Validation, Biomarker Scoring, Companion Diagnostics.
- Where is Nucleai located?
- Nucleai is based in Tel Aviv-Yafo, Israel and serves Tel Aviv-Yafo.
- Who is Nucleai for?
- Nucleai serves Pharmaceutical companies developing next-gen therapeutics and Research institutions focused on spatial biology.
What this business does
Nucleai is a software company based in Tel Aviv-Yafo, Israel.
- Provides Biomarker Discovery & Validation and Biomarker Scoring
- Specializes in geospatial ai methods for cellular analysis
- Serves pharmaceutical companies developing next-gen therapeutics
Structured summary
Vizoryo ran a data-consistency check on this profile: it read 5 public sources and compared the core details (name, phone, address, city, category, website) across them. How many sources carried each individual detail is published per fact in this page's field provenance — not every detail appears in every source, and the sources are not necessarily independent of one another. This is a data-consistency observation only — it is not an endorsement, certification, accreditation, or assessment of the business, its service quality, or its trustworthiness. Data consistency: 67% — this measures how consistently the business's name, phone, city, address, website, and category appear across the public sources read. It is not a rating of the business. Vizoryo status: Auto-indexed. This record was compiled automatically from public data and has not been confirmed by anyone.
- Business name
- Nucleai
- Category
- Software Company
- Industry
- Software Company - AI-Driven Diagnostics
- Location
- Tel Aviv-Yafo, Israel
- Official website
- https://nucleai.ai/
- Profile data (JSON)
- https://www.vizoryo.com/api/index/profile/nucleai-tel-avivyafo-br4c
- Summary
- Developing AI-driven diagnostic solutions, Nucleai applies geospatial AI methods for cellular analysis to support pharmaceutical companies and research institutions. The Tel Aviv-based organization specializes in biomarker discovery and validation, biomarker scoring, and companion diagnostics. It serves drug developers focused on next-generation therapeutics and spatial biology research.
- AI readability score (how completely this record is structured for AI systems to read; not a rating of the business)
- 29
- Data Consistency
- 67% (checked 2026-07-06)
- Record status
- Auto-indexed
- Sources cross-checked
- 5 public sources
Location
Tel Aviv-YafoIL
About Nucleai
Developing AI-driven diagnostic solutions, Nucleai applies geospatial AI methods for cellular analysis to support pharmaceutical companies and research institutions. The Tel Aviv-based organization specializes in biomarker discovery and validation, biomarker scoring, and companion diagnostics. It serves drug developers focused on next-generation therapeutics and spatial biology research.
Service areas
- Tel Aviv-Yafo
Target audience
- Pharmaceutical companies developing next-gen therapeutics
- Research institutions focused on spatial biology
- Drug developers needing AI-driven diagnostic solutions
Specialties
- Geospatial AI methods for cellular analysis
Social profiles
Frequently asked questions
What areas does Nucleai serve?
Nucleai serves Worldwide.
What imaging modalities does Nucleai's platform support?
The platform supports various imaging modalities including H&E, IHC/Multiplex IHC, Multimodal, and Multiplex IF/Multiplex Immunofluorescence.
Which therapeutic areas does Nucleai focus on?
Nucleai focuses on immunology and oncology, addressing indications such as Breast Cancer, Lung Cancer/NSCLC, and Colorectal Cancer.
Languages supported
- en
Contact
Official website: https://nucleai.ai/